Bolt Jennifer, Semchuk William, Loewen Peter, Bell Ali, Strugari Caitlin
BScPharm, ACPR, PharmD, is Residency and Education Coordinator, Department of Pharmacy Services, Regina Qu'Appelle Health Region, Regina, Saskatchewan.
MSc, PharmD, FCSHP, is Manager of Clinical Pharmacy Services, Department of Pharmacy Services, Regina Qu'Appelle Health Region, Regina, Saskatchewan.
Can J Hosp Pharm. 2015 Jul-Aug;68(4):290-5. doi: 10.4212/cjhp.v68i4.1468.
The participation of pharmacists on cardiopulmonary resuscitation (CPR) teams has been associated with improvements in patient outcomes secondary to lower rates of adverse drug events and higher rates of compliance with guidelines for advanced cardiac life support (ACLS). The degree to which Canadian pharmacists participate on CPR teams and the services they provide have not previously been assessed.
To measure the frequency of pharmacists' involvement on CPR teams in Canadian health care delivery organizations, to characterize the services provided by these pharmacists, to identify positive predictors of participation, and, for health care delivery organizations without pharmacists on CPR teams, to determine the reasons for the lack of involvement.
An electronic survey was distributed to key informants in Canadian health care delivery organizations. The survey consisted of questions about characteristics of the health care delivery organizations, pharmacists' participation and role on the CPR team, training, and barriers to implementation. The primary outcome was the percentage of health care delivery organizations with pharmacists participating on CPR teams in at least one centre within the organization. The secondary outcomes were pharmacists' activities, training, and reasons for not participating on CPR teams.
Forty-three of 99 key informants responded to the survey. Twenty-nine respondents (67%) indicated that their organization had a CPR team, and 10 (23%) indicated participation by pharmacists on a CPR team. Roles reported to be performed by pharmacists during CPR events were provision of drug information, preparation and administration of medications, record-keeping, and chest compressions. Training for these pharmacists was variable: ACLS training for 4 (40%) of the 10 organizations with pharmacist participation, in-house training for 3 (30%), and no training for 2 (20%); one respondent (10%) did not report the level of training. Reasons for not having pharmacists on CPR teams included inconsistent coverage, lack of training, and staff shortages.
This study characterized current pharmacist participation on CPR teams in Canadian health care delivery organizations. As evidence arises showing the impact of this practice on patient outcomes, pharmacist participation on CPR teams may become more common.
药剂师参与心肺复苏（CPR）团队与患者预后改善相关，这是由于药物不良事件发生率降低以及高级心脏生命支持（ACLS）指南的依从率提高。加拿大药剂师参与CPR团队的程度及其提供的服务此前尚未得到评估。
衡量加拿大医疗保健机构中药剂师参与CPR团队的频率，描述这些药剂师提供的服务，确定参与的积极预测因素，对于没有药剂师参与CPR团队的医疗保健机构，确定其未参与的原因。
向加拿大医疗保健机构的关键信息提供者发放电子调查问卷。该调查包括有关医疗保健机构特征、药剂师在CPR团队中的参与情况和角色、培训以及实施障碍的问题。主要结果是在机构内至少一个中心有药剂师参与CPR团队的医疗保健机构的百分比。次要结果是药剂师的活动、培训以及不参与CPR团队的原因。
99名关键信息提供者中有43人回复了调查。29名受访者（67%）表示其机构有CPR团队，10名（23%）表示有药剂师参与CPR团队。据报告，药剂师在CPR事件中执行的角色包括提供药物信息、准备和给药、记录保存以及胸外按压。这些药剂师的培训情况各不相同：10个有药剂师参与的机构中有4个（40%）接受了ACLS培训，3个（30%）接受了内部培训，2个（20%）未接受培训；1名受访者（10%）未报告培训水平。没有药剂师参与CPR团队的原因包括覆盖不一致、缺乏培训和人员短缺。
本研究描述了加拿大医疗保健机构中目前药剂师参与CPR团队的情况。随着有证据表明这种做法对患者预后有影响，药剂师参与CPR团队可能会变得更加普遍。
